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1 Abstract 
Background: This study is based on the hypothesis that functional Magnetic 
Resonance Imaging (fMRI) indices in the dorsolateral prefrontal cortex (DLPFC) of 
schizophrenia patients are spatially more heterogeneous than healthy controls for 
activation evoked by a working memory (WM) task. Patients have shown to have greater 
activation than controls in the DLPFC, but this seems to cancel out when performing 
group averages, which could be explained by patients having more spatially distributed 
activation. This may one of the causes for discrepant findings concerning hypo- or 
hyperactivation in the DLPFC of patients when performing a WM task. 
Methods: The cohort consisted of demographically matched schizophrenia 
patients and healthy controls. fMRI data was acquired to study the activation evoked by 
a modified Sternberg Item Recognition Paradigm (SIRP) known to induce robust 
activation of the main brain areas subserving WM both in schizophrenia patients and 
healthy controls. Those areas are the DLPFC, the intraparietal sulcus, the insula and the 
primary motor cortex. The fMRI data was analyzed with the FMRIB Software Library 
(FSL). We limited the analysis to the DLPFC by filtering the data with a region of interest 
(ROI) individually defined for each subject based on its own brain anatomy and 
conservative Talairach coordinates. For the study of fMRI indices, we used the centers of 
gravity (COG) of activation clusters. The COG is a 3 dimensional coordinate (x, y, z) 
computed based on the z-values of all voxels constituting a cluster. 
Results: The paradigm induced activation in the brain areas known to be involved 
in WM. In response to the WM paradigm, the COGs of the activation clusters in the 
DLPFC had a significantly greater spatial heterogeneity in patients compared to controls 
in the left hemisphere. The right hemisphere did not show any significant difference 
between the two groups. 
Conclusion: Our hypothesis is supported by our findings in the left hemisphere, but 
not the right. The methods that were developed for this study are a first attempt to study 
the spatial heterogeneity of the activation in the DLPFC. The power of the results would 
benefit from improvement of those methods. In particular, the definition of the DLPFC 
ROI is to be improved in order to better target the activation patterns of interest. 
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2 Abbreviations 
ART: functional Magnetic Resonance Imaging Artifact Detection Tools 
BA: Brodmann area 
BET: brain extraction tool 
BIRN: Biomedical Informatics Research Network 
CT: computed tomography 
COG: center of gravity 
COPE: contrast of parameter estimate 
D2 receptor: dopamine receptor 2 
DLPFC: dorsolateral prefrontal cortex 
DSM IV: Diagnostic and Statistical Manual of Mental Disorder, 4th edition 
DTI: diffusion tensor imaging 
EV: explanatory variable 
ED: Euclidian distance 
FA: fractional anisotropy 
FA: flip angle 
fBIRN: Functional Biomedical Informatics Research Network 
FE: fixed-effect modeling 
FEAT: fMRI Expert Analysis Tool 
FILM: FMRIB's Improved Linear Model 
FIPS: Functional Biomedical Informatics Research Network (fBIRN) Image 
Processing Stream 
FLIRT: FMRIB's Linear Image Registration Tool 
fMRI: functional Magnetic Resonance Imaging 
FOV: field of view 
FSL: fMRIB Software Library 
FWHM: full width at half maximum 
GLM: general linear model 
IOWA: University of Iowa 
IRB: Institutional Review Board 
MCFLIRT: Motion Correction using FMRIB's Linear Image Registration Tool 
MCIC: Mental Illness and Neuroscience Discovery (MIND) Institute Clinical 
Imaging Consortium 
MGH: Massachusetts General Hospital 
MIND: Mental Illness and Neuroscience Discovery 
MRI: Magnetic Resonance Imaging 
NEX: number of excitations 
PE: parameter estimate 
PET: positron emission tomography 
QA: quality assurance 
rCBF: regional cerebral blood flow 
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RFT: random field theory 
ROI: region of interest 
SIRP: Sternberg Item Recognition Paradigm 
SLF: superior longitudinal fasciculus 
SNP: single nucleotide polymorphism 
TE: echo time 
TR: repetition time 
UMN: University of Minnesota 
UNM: University of New Mexico 
VLPFC: ventrolateral prefrontal cortex 
WM: working memory 
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3 Introduction 
Schizophrenia is a psychiatric disease caused partially by genetics and partially by 
environmental factors. It is currently treated with different kinds of antipsychotic 
medication. Those treatments have been able to considerably improve patients’ daily 
life, but no drug has yet had the capability to fully cure a patient. Antipsychotic drugs 
target the dopamine signaling system in the brain thought to be the main cause of 
schizophrenic symptoms, such as psychosis. 
Schizophrenia patients have been shown to be impaired in the performance of 
working memory (WM) tasks. This impairment underlies many aspects of the disease, 
such as disorganized speech and difficulties in planning and decision-making based on 
external stimuli leading to a significant lowering of the quality of life for the affected 
patients as well as their close surroundings. 
In this study we use functional Magnetic Resonance Imaging (fMRI) to investigate 
whether schizophrenia patients activate the dorsolateral prefrontal cortex (DLPFC), our 
region of interest (ROI), in a different fashion compared to healthy controls in response 
to a WM paradigm. We use a modified Sternberg Item Recognition Paradigm (SIRP) in 
order to elicit activation of the WM network. This hypothesis is based on previous 
findings suggesting a spatially more heterogeneous activation in patients’ DLPFC while 
performing a working memory task. We use the measure of spatially localized centers of 
gravity (COG) of clusters of activation in order to assess for the potential differential 
activation pattern in patients relative to controls. 
In the following chapter, we will define the main concepts of this study, which are 
schizophrenia, functional Magnetic Resonance Imaging, and working memory. In 
parallel, based on scientific literature, we will present a subset of previous findings that 
form the foundations for our present hypothesis. 
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4 Background information 
4.1 Schizophrenia: 
While schizophrenia is a psychiatric disorder known to alter intelligence, social 
behavior, affect, it is typically a disorder of cognition (Kandel, Schwartz, & Jessell, 
2000). Schizophrenia was at first seen as a purely psychiatric disorder. Nevertheless, 
with the advancements of neuroscience, it is now clear that schizophrenia has an 
associated genetic causality (Gur, et al., 2007, p. xxii; Yudofsky & Hales, 1994). 
Schizophrenia is a neuropsychiatric disease with a worldwide prevalence of about 1%, 
with a predominance in males (Kandel, et al., 2000). Although schizophrenia has been 
studied for several decades, there remain many aspects that need to be more thoroughly 
investigated in order to fully understand the course and outcome of the disease as well 
as improve its treatment. 
4.1.1 Characteristics 
Schizophrenia is a heterogeneous syndrome. It is a disease with early onset, 
usually in late adolescence (Reus, 2008). The Diagnostic and Statistical Manual of 
Mental Disorders, 4th edition, (DSM IV) (American Psychiatric Association, 1994) 
describes schizophrenia as the presence of at least two of the five characteristic 
symptoms listed below for a considerable duration over a one-month time frame: 
 
1. Delusions; ‘an idiosyncratic belief or impression that is firmly maintained despite 
being contradicted by what is generally accepted as reality or rational argument, 
typically a symptom of mental disorder’1. 
 
2. Hallucinations; ‘an experience involving the apparent perception of something 
not present’2. 
 
3. Disorganized speech (e.g. frequent derailment or incoherence). 
 
4. Grossly disorganized or catatonic behavior. 
 
5. Negative symptoms (deficit); i.e. affective flattening, alogia (absurdity, confusion, 
irrationality, or speechlessness3), or avolition (having no will or energy to 
undertake actions4). 
                                            
1 ("Oxford American Dictionaries," 2005) 
2 ("Oxford American Dictionaries," 2005) 
3 ("English Wiktionary," 2009) 
4 ("Oxford American Dictionaries," 2005) 
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Characteristic symptoms 1 to 4 are called psychotic (positive) symptoms in contrast 
to the deficit (negative) symptoms listed under number 5. 
In addition to the characteristic symptoms, an affected person usually has social 
and/or occupational dysfunction (American Psychiatric Association, 1994). The patient 
has difficulty in handling the main aspects of daily life, like socializing, handling one’s 
working environment and basic self-care. 
 
DSM IV classifies schizophrenia in five subtypes: 
 
1. Paranoid type; the characteristic symptoms are mostly delusions and auditory 
hallucinations. 
 
2. Disorganized type; the prominent symptoms are disorganized speech and 
behavior, as well as a flattened affect. 
 
3. Catatonic type; defined by several features, not all having to be present in one 
patient: catatonia, excessive and incoherent movements, mutism, and grimacing. 
 
4. Undifferentiated type; no symptoms allow a specific classification beyond the 
characteristic symptoms. 
 
5. Residual type; this type is defined as the presence of mostly negative symptoms, 
and sometimes weakened manifestations of two of the characteristic symptoms. 
 
Patients with schizophrenia are psychosocially impaired and have difficulties in 
finishing their education. They have impaired neurocognitive functions such as memory, 
attention, executive functions (‘the ability to absorb and interpret information and make 
decisions based on that information’5) and motor speed. This explains some typical 
facets of the disease like having poor social problem-solving skills, poor community 
functioning, and not being able to acquire new skills (Green, 1996). 
Neuroleptic medications have been proven to treat some psychotic aspects of the 
disease like hallucinations and delusions, and some atypical antipsychotics have proven 
successful in improving the WM (Green, et al., 1997). However, most neuroleptics are 
not successful at significantly ameliorating the cognitive functions needed for a normal 
daily life (Goldberg & Weinberger, 1996; Ragland, Yoon, Minzenberg, & Carter, 2007). 
Consequently, more research needs to be done in order to make advancements in the 
psychosocial and pharmacological treatments of schizophrenia. fMRI studies could lead 
to a better understanding of what the dysfunctions related to the disease are and to the 
development of novel therapies aiming at the improvement of patients’, as well as their 
families’, quality of life. 
                                            
5 ("NIMH: What are the symptoms of schizophrenia," 2009) 
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4.1.2 Origins of the disease and the dopamine hypothesis 
A frequent and mostly unanswered question concerning many psychiatric diseases, 
including schizophrenia, is what proportion of the causes can be explained by innate 
(genetics) or acquired (environmental) features. In the case of schizophrenia there are 
most probably multiple genes involved in disease etiology. In particular, it is very likely 
that it is caused by the combination of various polymorphisms of the several genes. 
6.6% of first-degree relatives of a patient have some form of schizophrenia and the 
offspring of two schizophrenic people has a 40% risk of developing the disease (Reus, 
2008). 
Early positron emission tomography (PET) studies have made contradicting 
observations on the affinity and the density of dopamine receptor (D2) in the basal 
ganglia of schizophrenia patients. Some have found a significant increase in D2 receptors 
in untreated patients versus controls (Wong, et al., 1986), whereas others did not find 
any significant difference (Farde, et al., 1990; Martinot, et al., 1990). 
Roffman et al. (2008) specify that several genes are involved in causing the disease, 
and particular combinations of certain genes and polymorphisms could contribute to a 
higher risk. In particular, the dopamine signaling in the prefrontal cortex is thought to be 
dysfunctional in schizophrenia patients and impairs their WM. Roffman says the genetics 
behind it are complex but that the dysfunctioning is partly linked to polymorphisms in 
the Catechol-O-methyl transferase (COMT) and the methylenetetrahydrofolate reductase 
(MTHFR) genes. Beyond genetics, the causes of the disease could be a development 
abnormality, a perinatal injury, or a viral infection (Kandel, et al., 2000). 
COMT is considered as a susceptibility gene in the list of various causes of 
schizophrenia (Reus, 2008). The COMT protein is an enzyme that breaks down the 
dopamine present in the synapses. Sawaguchi & Goldman-Rakic (1991) have 
demonstrated the importance of dopamine signaling in the prefrontal cortex of rhesus 
monkeys for the performance of WM tasks. In the DLPFC in particular, a deficient 
COMT enzyme leads to partial inhibition of the dopamine inactivation in the synapses. 
A single nucleotide polymorphism (SNP) in the COMT gene causes a valine amino acid 
to turn into a methionine amino acid (158Val→Met). People with the methionine allele 
will have more dopamine in the synapses because of a less efficient COMT enzyme 
leading to increased dopamine signaling. Drugs reducing dopamine activity 
(antipsychotic agents) have been successful at treating some symptoms such as 
psychosis, hallucinations and anxiety, but are often accompanied by several side-effects 
due to hypoactive dopamine signaling (Reus, 2008). The main principle of action of 
these drugs is to bind post-synaptically on dopamine receptors D2/D3. They are 
dopamine antagonists. 
Related to the DLPFC in particular, dopamine signaling is thought to follow an 
inverted U-shaped curve, where too much dopamine is as disabling as too little in terms 
of working memory performance (Roffman, Gollub, et al., 2008). 
Also thought to be involved in schizophrenia is a SNP in the MTHFR gene 
(677C→T) acting indirectly on the dopamine signaling through COMT (Roffman, Gollub, 
et al., 2008). The MTHFR C/C genotype increases the dopamine in the prefrontal cortex. 
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But, because of the inverted U shaped curve of DLPFC activation as a function of 
amount of dopamine, the increase might not always be beneficial. Anyhow, it has been 
suggested that the T allele on the MTHFR gene in concert with the Val allele of the 
COMT gene cause significant executive function deficits in schizophrenia patients 
shifting them to the left of the inverted U performance curve (Roffman, Weiss, et al., 
2008). 
4.2 Magnetic Resonance Imaging 
The advent of brain imaging techniques has revolutionized the way in which 
brains can be studied. It is namely a noninvasive technique that allows the exploration 
of multiple features of the brain in vivo, anatomically with Magnetic Resonance Imaging 
(MRI), functionally with fMRI and in terms of connectivity with the more recent 
technique of Diffusion Tensor Imaging (DTI). The quality and the accuracy of the images 
resulting from the various MRI techniques are subject to constant evolution and 
improvements. These techniques present the great advantage, compared to postmortem 
studies, of allowing the in vivo study of diseases such as schizophrenia and thereby link 
observations made on the functionality and brain structure to actual cognitive deficits 
and other symptoms. 
MR images are acquired with MR scanner. Coils send radiofrequencies exciting the 
protons (hydrogen atoms), also called spins, in the tissue at their resonance frequency, 
bringing them to a higher energy state (antiparallel state). When going back to a stable 
state (parallel state), the nuclei emit electromagnetic energy. The measurement of this 
energy is what yields the MR signal. 
Contrasts between different brain tissues (e.g. white matter, gray matter and 
cerebrospinal fluid) can be represented in an image due to MRI because it measures the 
type and the relaxation properties of the atomic nuclei, which are different in different 
tissues due to the differential molecular composition. This is used for the acquisition of 
anatomical high-resolution MRI images (T1- and T2-weighted images). 
A time constant, T1, defines the time excited high-energy nuclei need to go back 
the parallel (low-energy) state. The process is called T1 recovery and measures the 
longitudinal relaxation, i.e. the recovery of the longitudinal magnetization (along the z 
axis). The T1 contrast is used for acquiring structural MRI scans. 
The net magnetization of the spins in the transverse plane (x-y) also decreases over 
time after the excitation. The spins namely get more and more dephased relative to each 
other. This is the transverse relaxation process. The time constant defining this process is 
T2. The contrast is also used for the acquisition of structural MRI scans, but highlight 
different parameters than the T1 contrast. 
4.2.1 functional Magnetic Resonance Imaging 
fMRI is the technique used for the study of functional activation of the brain. It is 
based on the differential electromagnetic properties of oxygenated and deoxygenated 
 9 
hemoglobin. The proportion of oxygenated relative to deoxygenated hemoglobin in the 
brain is an indirect measure of the neuronal activity. 
For blood-oxygen-level dependent (BOLD)-contrast fMRI, the image acquisition is 
based on another time constant, the T2*. In addition to the natural dephasing of excited 
spins measured in T2-weighted images, the external magnetic field causes spatial 
inhomogeneities in the local magnetic field of the object. The signal decay that is 
measured is called T2* and is slightly shorter than T2. The applied radiofrequency pulse 
sequence needs to have a long repetition time (TR, the time interval between two 
excitation pulses) and a medium long echo time (TE, the time between the excitation 
pulse and the acquisition of the data). The amount of deoxygenated hemoglobin present 
in the brain is what describes the intensity of every voxel of the resulting T2*-weighted 
image. This is possible because oxygenated and deoxygenated hemoglobin react 
differently to the application of a magnetic field. 
Consequently, fMRI indirectly estimates the neuronal activity by measuring the 
magnitude of the change in deoxygenated hemoglobin present in the vasculature at a 
certain time. It creates images of the physiological activity, which in turn is correlated 
with the neuronal activity. T2*-weighted images show a higher signal where the amount 
of oxygenated hemoglobin is greater (i.e. where neuronal activity is greater). Neural 
activity requires an increase in local blood flow. The proportion of oxygenated 
hemoglobin relative to deoxyhemoglobin becomes greater because the supply of 
oxyhemoglobin exceeds the amount actually needed by the neuronal activity. 
Investigating the functionality of patients’ brains may help in the long term to link 
cognitive processes to specific behaviors and symptoms. Also, defining functional 
patterns and brain morphometry that are unique to schizophrenia patients could ease 
the diagnosis and serve as points of references for the progression of the disease. 
4.3 Functional localization in the brain 
Neuroanatomy studies have previously assigned different functions to different 
locations in the brain based on cytoarchitectonics (Brodmann, 1909). Today, many 
functions are rather thought to be executed by a particular network of brain areas, and 
not only requiring a single part of the brain. The consequences of having dysfunctioning 
areas of the cortex, the white matter, or sub-cortical structures of the human brain can 
be more or less disabling depending on the cases and the causes. A person with brain 
damage might show changes in behavior and personality and/or alteration in cognitive 
processing, such as judgment, memory and intellect. 
Before brain imaging, functional localization studies of the human brain were 
mainly performed on subjects with brain lesions. A detailed examination of their 
behavior and response to different stimuli could later be partially explained by post-
mortem dissections. The development of brain imaging techniques started in the 1970’s 
with computed tomography (CT), and continued with MRI in the beginning of the 
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1980’s6, and allowed for more rapid, eloquent and concise techniques for functional 
localization. 
4.3.1 Brain anatomy of schizophrenia patients and the lateral frontal lobe 
Brain anatomy characteristics of schizophrenia 
In (1992), Zigun and Weinberger published results on some particular anatomical 
observations made on the brains of patients with schizophrenia. Observations that have 
later been verified by other studies were, as listed in Synopsis of Neuropsychiatry7: 
 
Compared to healthy subjects, schizophrenia patients show: 
• Enlargement of the lateral ventricles 
• Enlargement of the third ventricle 
• Dilation of cortical sulci 
• Changes in temporal lobe structures 
The lateral frontal lobe 
The frontal lobe in humans can be separated into several subparts. It is known to 
be an architectonically very diverse region of the brain (Pandya & Barnes, 1987). Two 
main subdivisions of the lateral frontal lobe are the dorsolateral part and the frontal 
operculum. 
The frontal operculum includes Brodmann areas (BA) 44, 45 and 47. On the left 
hemisphere, BA 44 and 45 form Broca’s area, which is a key region for the good 
functioning of language production. A lesion in Broca’s area entails aphasia, or the 
inability to produce speech (Dronkers, Plaisant, Iba-Zizen, & Cabanis, 2007). In the right 
hemisphere, this area is rather involved in the non-lexical, or paralinguistic, features of 
language, such as pitch and volume8. 
The dorsolateral frontal lobe of the brain covers BA 8, 9, 46 and 109. In general, 
lesions in this area in the left hemisphere cause impaired ‘verbal intellect’, ‘defective 
recency and frequency judgments for verbal material’, ‘defective verbal fluency’ and 
‘impaired “executive functions”’, also called cognitive control, which involves, among 
other aspects, planning, rule learning, and prevention of inappropriate behaviors10. 
Lesions of the right dorsolateral frontal lobe involve ‘impaired nonverbal intellect’, 
‘defective recency and frequency judgments for nonverbal material’, ‘defective design 
fluency’, as well as impaired “executive functions”’11. 
                                            
6 (Tranel, 1994, p. 49) 
7 (Daniel, Zigun, & Weinberger, 1994, p. 146) 
8 (Tranel, 1994, p. 62) 
9 (Tranel, 1994, p. 67) 
10 (Strub & Wise, 1994, p. 199) 
11 (Tranel, 1994, p. 64) 
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More specifically, the DLPFC is most often defined as covering BA 9 and 46 
(Petrides, Alivisatos, Meyer, & Evans, 1993; Rajkowska & Goldman-Rakic, 1995b). 
Rajkowska & Goldman-Rakic (1995a, 1995b) have described after detailed 
cytoarchitectonic analyses of several postmortem human brains that BA 9 and 46 are 
highly variable in terms of location from one brain to another. Yet, beyond those 
variations, they show that in all individual brains they studied, BA 9 always covered part 
of the superior frontal gyrus, and BA 46 part of the middle frontal gyrus. They compare 
their observations with those made by other cartographers (Brodmann, 1909; Sarkissov, 
Filimonoff, Konokova, Preobrazenskaja, & Kukueva, 1955; von Economo & Koskinas, 
1925) and thereby confirmed the intersubject variability. Rajkowska & Goldman-Rakic 
(1995b) have mapped the area where BA 9 and 46 of the five brains they examined vary 
and overlap on the Talairach grid system (Fig. 1) (Talairach & Tournoux, 1988) and 
derived a set of conservative coordinates to describe them. The Talairach atlas is a 
common reference for using as a standardized space for the study of functional brain 
imaging. Petrides & Pandya (1999) have further investigated the cytoarchitectonics of BA 
9 and 46 and have defined a third area that they call BA 9/46 because it was previously 
accounted for being part of BA 9 but tends to have similar cytoarchitectonic criteria to 
BA 46 (Fig. 2). In summary, the frontal lobe is a highly evolved area of the brain and is 
therefore prone to great interindividual variation (Owen, 2000). 
Selemon et al. (2003) made neuronal density studies and found that BA 9 has a 
significantly higher neuronal density in schizophrenia than healthy controls, whereas 
other areas of the brain did not show any significant difference, suggesting BA 9 as a 
target area of the disease. 
 
 
Fig. 1: Cytoarchitectonically defined BA 9 and BA 46 of five brains overlaid on lateral left 
hemisphere of the Talairach and Tournoux stereotaxic coordinate system. Red shows overlap of the five 
brains. Dark blue area is covered by only one brain. 
(Image taken from (Uylings, Rajkowska, Sanz-Arigita, Amunts, & Zilles, 2005) who adapted it from 
(Rajkowska & Goldman-Rakic, 1995b)) 
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Fig. 2: BA 9, BA 46 and BA 9/46 as defined by Petrides & Pandya (1999). 
(Image taken from (Petrides & Pandya, 1999)) 
4.4 Working memory and schizophrenia 
Working memory enables one to simultaneously store and manipulate information 
temporarily for use in cognitive operations such as understanding language, reasoning 
and learning, and devising plans for the further guiding of one’s behavior (Baddeley, 
1992). Baddeley proposed a multicomponent model comprising an attentional control 
system, the ‘central executive’, and two underlying systems responsible for temporary 
storage and manipulation of visual material, the ‘visuospatial sketchpad’, and verbal 
material, the ‘phonological loop’ (Fig. 3). In other words, a functioning WM is critical to 
successfully remember a phone number during a short time span as well as to perform 
more demanding cognitive tasks such as behavioral planning. 
 
Fig. 3: Baddeley’s multicomponent model of working memory. 
(Image taken from (Baddeley, 1992)) 
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Consequently, typical signs of schizophrenia, like disorganized speech, thought 
disorder, avolition or alogia, can be partially explained by an impaired working memory 
linked to the difficulties in keeping a linguistic plan in mind (Ragland, et al., 2007). 
Delusions or hallucinations could be the consequences of not having the ability to 
compare a new stimulus with the associative memories. Several studies have 
demonstrated that schizophrenia patients show poor skills in the performance of WM 
tasks (Barch, et al., 2001; Goldman-Rakic, 1994; S. Park & Holzman, 1992). 
4.4.1 Dorsolateral prefrontal cortex and working memory 
WM tasks are known to involve several brain parts such as the supplementary 
motor area, the lateral premotor and primary motor areas, the insula, the intraparietal 
sulcus, and the DLPFC (Cohen, et al., 1997; Jonides, et al., 1998; E. E. Smith, Jonides, 
Marshuetz, & Koeppe, 1998). This project focuses on the activity in the DLPFC, known 
to be a key area required for the processing of WM tasks (Goldman-Rakic, 1994; 
Manoach, et al., 1997; McCarthy, et al., 1996) and robustly responding to the SIRP. 
The first studies on blood flow in the DLPFC of schizophrenia patients were 
performed on subjects in resting state (Ingvar & Franzen, 1974; Petrides, et al., 1993; 
Weinberger, Berman, & Zec, 1986). This proved to be the wrong approach as there 
could be no control on the mental activity and hence no reliable replication of results. 
That is why research groups started to study cognitive aspects instead, giving more 
insight into task related activation (Ragland, et al., 2007). 
Early evidence of the involvement of the DLPFC in the WM network was at first 
suggested by studies based on humans that had had partial excision of the frontal lobe 
(Owen, Sahakian, Semple, Polkey, & Robbins, 1995; Petrides & Milner, 1982). Petrides 
et al. (1993) demonstrated the implication of the DLPFC in the network underlying WM 
in humans with PET studies. Later, Goldman-Rakic (1994) defined the network involved 
in working memory in non-human primates. She found with the help of lesion studies, 
tract tracing, studies of cerebral metabolism and in vivo single cell recording that the 
DLPFC is a key component of the WM network. 
4.4.2 Hypo/hyperfrontality theory 
Groups have claimed to find both hypoactivation (Berman, Torrey, Daniel, & 
Weinberger, 1992; Berman, Zec, & Weinberger, 1986; Cannon, et al., 2005; Driesen, et 
al., 2008) and hyperactivation (Callicott, et al., 2000; Manoach, et al., 1999) of the 
DLPFC in schizophrenia patients using their WM in fMRI studies. Berman et al. (1986) 
have demonstrated that both medicated and unmedicated schizophrenia patients have a 
significantly different regional cerebral blood flow (rCBF) specifically in the DLPFC 
while performing a WM task and when compared to healthy controls. Healthy controls 
have an increased blood flow while performing the task, whereas patients don’t. The 
theory claims that the increase in blood flow is correlated to the performance at the task, 
hence explaining the lower performance of schizophrenia patients. Berman et al. (1992) 
have also shown a decrease in the rCBF in the prefrontal cortex in schizophrenic twins, 
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compared to the healthy sibling twin during the performance of a cognitive task, 
supporting the hypofrontality activation theory of schizophrenia and suggesting it is not 
caused only by genetics. Driesen et al. (2008) show that the activation in the DLPFC 
related to a WM task decreases more in patients than controls over time. This 
hypoactivation in patients does not seem to be linked to medication. Cannon et al. 
(2005) also claim that schizophrenia patients hypoactivate the DLPFC compared to 
controls, and prove that this difference is not seen in any other area of the brain involved 
in working memory task processing. 
In contrast, some groups rather claim the hyperactivation of the DLPFC in 
schizophrenia. The hypothesis behind this is mostly explained by the ‘inefficiency’ 
theory: the more difficult the task, the poorer the performance but the more the brain is 
recruited in order to compensate for the weakened performance. Indeed, patients have 
shown to activate the DLPFC more than controls but for worse performance at the WM 
task (Callicott, et al., 2003). More precisely, Manoach et al. (1999) argue for that 
difference in activation only being significant in the left DLPFC. Manoach et al. (2000) 
suggest that previous findings of hypoactivation might have been observed because of 
lack of motivation from the patients’ side to perform the task at their best. 
Discrepancies between findings of either hypo- or hyperactivation of the DLPFC 
can be caused by different tasks used in different studies, making the studies 
incomparable. Even if all tasks require the use of WM, some widely used ones, like the 
Wisconsin Card Sorting Test, also tests for other functions (e.g. task switching, 
maintenance of attention, concept formation (Sullivan, et al., 1993)). 
The relation between activation in the DLPFC and increasing WM load is not a 
linear one. It has been observed that both for patients (Manoach, 2003) and healthy 
controls (Callicott, et al., 1999; Goldberg, et al., 1998) activation in the DLPFC may 
decrease or simply not increase anymore when reaching a certain level of cognitive 
load, i.e. a level that exceeds the subject’s capacity. That is, when the task becomes too 
complex, the activity in the DLPFC is not increasing anymore, or even decreases, while 
performance declines. That cognitive load threshold at which performance starts to 
decline is lower for patients than for controls. This model corresponds to an inverted U-
shaped curve of DLPFC activation versus increase in working memory load (Fig. 4). The 
hypoactivity found in some studies might be caused by tasks using too high loads of 
working memory. When the complexity of a task exceeds a manageable threshold, 
subjects may start guessing or simply feeling helpless and not focus on the assignment 
anymore (Manoach, 2003). 
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Fig. 4: Increase in working memory load shows an inverted-U shaped curve of the activation in the 
DLPFC. The maximum activation is attained at lower memory loads for schizophrenia patients compared 
to healthy controls. 
(Image taken from (Manoach, 2003)) 
 
Karlsgodt et al. (2009) have come up with a new model to explain these 
differences in activation. They further separate groups of patients and controls into high 
and low performers. They claim and demonstrate that high performing controls need 
fewer resources to complete the same task as low performers, causing low performing 
controls to hyperactivate, leading to a greater percent signal change from baseline. In 
contrast, high performing schizophrenia patients seem to activate the DLPFC 
significantly more that low performing ones. 
4.4.3 Hypothesis on the heterogeneity of DLPFC activation 
Manoach et al. (2000) found a novel way of explaining the hypofrontality found by 
certain groups. First, they suggest that the impaired working memory in schizophrenia 
may be caused either by dysfunction of the DLPFC or some remote cortical or 
subcortical structure regulating the DLPFC. Moreover, they show that the fMRI indices of 
activity in the DLPFC of patients are not overlapping those of the controls. Most of the 
areas that both patients and controls activate in common show notable overlap, except 
for the DLPFC. They analyzed results from both individual subjects and averaged group 
data. Interestingly, they found that in individual subjects, schizophrenia patients had a 
larger number of active voxels in the DLPFC than controls. However, when subjects 
were averaged together into groups of patients versus controls, the number of active 
voxels in the DLPFC was larger for healthy controls. The following observation was that 
only 24% of the activation clusters in each patient overlapped the patient’s group 
cluster, whereas the controls showed a 71% overlap with the control’s group cluster. 
Relative to controls, schizophrenic subjects are therefore thought to have higher but 
more spatially heterogeneous activation in the DLPFC. Hypoactivation in the frontal 
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lobe of patients performing WM tasks has nevertheless been shown in individual 
subjects (Barch, et al., 2001; Stevens, Goldman-Rakic, Gore, Fulbright, & Wexler, 1998). 
Weinberger & Berman (1996) and Holt et al. (1999) have confirmed the aberrant 
activation of the DLPFC in schizophrenia patients related to WM tasks compared to 
healthy controls. 
Another interesting hypothesis is that schizophrenia prevents the automation of a 
task thereby leading to more variability in the results after several repetitions compared 
to healthy controls. A normal subject would learn the best way of treating a task and 
adapt with time. But a patient repeating a task would have a hard time building up a 
strategy. Automation results in greater efficiency and more behavior and spatially more 
reliable patterns of activation (Manoach, 2003). 
4.4.4 Brain connectivity 
Cohen et al. (1997) have suggested the involvement of both frontal and parietal 
brain areas in the processing of WM tasks. Petrides (1996) even discriminated the 
connection from the parietal cortex to the ventrolateral prefrontal cortex (VLPFC) and the 
DLPFC depending on the type of processing. The functional connection between the 
VLPFC and the DLPFC has been shown to be very strong (R. Schlosser, et al., 1998). 
Schlosser et al. (2003) have later suggested that medicated schizophrenia patients show 
a reduction of the prefrontal-cerebellar connectivity, but a strengthened thalamo-cortical 
connectivity. DTI studies have suggested changes in the structure of the white matter in 
the medial temporal lobe and the DLPFC of the right hemisphere of schizophrenia 
patients, and a correlation between the hemodynamic response of the DLPFC and this 
reduction in white matter (R. G. Schlosser, et al., 2007). 
The main white matter connection between the frontal and the parietal cortex is 
the superior longitudinal fasciculus (SLF). DTI measures the fractional anisotropy (FA), 
which is correlated to the integrity of the white matter. Karlsgodt et al. (2008) have 
found a reduction in the FA of the SLF in schizophrenia patients, especially in the left 
hemisphere. Interestingly, they could link that reduction of the FA to a lower 
performance at a verbal WM task emphasizing the functional importance of the fronto-
parietal connectivity. Hence, abnormalities in the white matter of patients may cause 
differential patterns of activation as compared to healthy controls. 
Makris et al. (2005) use in vivo DTI to show that the SLF can be divided into four 
subcomponents as previously found in non-human primates (Petrides & Pandya, 1984). 
They suggest that the findings made in primates can be translated to humans and report 
that the SLF is in fact four separate fascicles: SLF I, SLF II, SLF III, and the arcuate fascicle 
(AF), all lying adjacent to one other. 
SLF I was found to connect the medial/dorsal parietal lobe to both dorso-
frontal/dorso-medial prefrontal regions and dorsal premotor areas. SLF II, said to be the 
main subdivision of the SLF, was shown to run from the angular gyrus (caudal-inferior 
parietal area) to the caudal-lateral prefrontal area/middle frontal gyrus (BA 6, 8 and 46) 
passing on top of the insula. SLF III was suggested to connect the supramarginal gyrus to 
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the ventral premotor and prefrontal areas. The arcuate fasciculus runs from the posterior 
part of the superior temporal gyrus to the lateral prefrontal cortex (BA 8 and 46), passing 
over the insula and the Sylvian fissure, joining the SLF II. Makris et al. suggest the 
function of SLF II to be involved in the understanding of the visual space. The group also 
suggests the possibility that SLF II has a role in spatial working memory, because of its 
connection to BA 46. 
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5 Materials & Methods 
5.1 Sternberg Item Recognition Paradigm - SIRP 
A modified version of the SIRP was used to assess WM (Sternberg, 1966). The SIRP 
is a block design task consisting of a phase of encoding of a set of 1, 3 or 5 digits (load 1 
= low, load 3 = medium or load 5 = high WM load) followed by a blocked sequence of 
1-digit probes (Fig. 5). This paradigm has been previously shown to consistently activate 
the DLPFC in healthy controls and schizophrenia patients, both performing above 
chance level (Manoach, et al., 1999; Manoach, et al., 1997; Rypma, Prabhakaran, 
Desmond, Glover, & Gabrieli, 1999). 
The subject had to report whether the probe digit was part of the encoding 
sequence (a target) or not (a foil). Subjects responded by pressing the ‘target’ or the ‘foil’ 
button, the buttons were randomly assigned to either the right or the left thumb (one 
button in each hand) according to their study ID to prevent handedness effects. Subjects 
were directed to be as accurate and quick as possible. There was a $0.05 bonus for 
every correct response to prevent lack of motivation and biased results. 
 
Fig. 5: The Sternberg Item Recognition Paradigm. See text for details. 
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The subjects underwent three runs of the task in total. Each run comprised 2 blocks 
of each memory load presented in a random order, for a total of 6 blocks per run. A run 
started with 6 seconds of fixation on a cross. The subject was then prompted for 1.5 
seconds by the word ‘Learn’ displayed on the screen (learn condition). After a 0.5 
second delay, a sequence of 1, 3 or 5 digits, depending on the task’s load, appeared for 
6 seconds in red (encode condition). Following a 1 second delay, the 14 probes were 
displayed one after the other in a random sequence for 1.1 seconds each in green with a 
random delay of 1.543 seconds on average between every probe (probe condition). Half 
the probes were targets, and half were foils. The duration of a block was 46 seconds 
with a random fixation time between every block being 12 seconds on average, and the 
last fixation block being set to 14 seconds. Therefore, a run totaled 360 seconds in 
duration. The paradigm was programmed with the EPrime presentation software, which 
also recorded the behavioral response information (reaction time and accuracy). 
5.2 Subjects 
All brain imaging data had been originally collected as part of the Mental Illness 
and Neuroscience Discovery (MIND) Institute Clinical Imaging Consortium (MCIC) 
Study. This consortium was created for the study of first-episode and chronic 
schizophrenia. Its primary clinical aim is the identification of the neural substrates of the 
core cognitive deficits associated with schizophrenia, their link to the clinical features of 
the disorder and their alterations with disease progression and treatment. It is a 
partnership between four sites: the University of New Mexico (UNM), the University of 
Minnesota (UMN), the University of Iowa (IOWA) and the Massachusetts General 
Hospital (MGH). 
The following study is limited to the subjects coming from the MGH site. Initially 
there were 64 subjects: 38 patients and 26 matched controls. 59 subjects (35 patients 
and 24 controls) passed the quality assurance for the whole brain analysis. 47 subjects 
passed the quality assurance process for the ROI analysis (see section 5.8 ), whereof 32 
were patients and 15 were controls. The controls were demographically matched to the 
patients with regard to gender, age, education and parental socioeconomic status (Table 
1). Schizophrenia diagnosis was based on the criteria listed in the DSM IV, and a 
Structured Clinical Interview for DSM disorders (SCID). 
 
Table 1: Demographic data. Means, standard deviations and group comparisons. 
Subject characteristics 
Normal subjects 
(n=15) 
Schizophrenic 
subjects (n=32) 
t p 
Gender (% female) 33 28 - - 
Age 40.67 ± 9.74 37.34 ± 10.15 0.3 0.38 
Education (years) 15.68 ± 2.01 12.03 ± 2.69 2.34 0.99 
Parental socioeconomic 
status (low score denotes 
high status) 
2.93 ± 0.77 3.2 ± 1.02 0.31 0.76 
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5.3 MRI and fMRI 
Structural Magnetic Resonance Imaging – MRI: 
Both T1 (MP-RAGE) and T2 gradient-echo (GRE) anatomical scans, as well as 
phase and magnitude field maps for image distortion correction, were acquired on a 1.5 
Tesla Siemens Sonata scanner. The scanning parameters are listed in Table 2. 
Table 2: MRI scanning parameters. T1 scan: acquired with a spoiled GRASS (gradient recalled 
acquisition in the steady-state) sequence. T2 scan: echo train length of 1. 
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Functional Magnetic Resonance Imaging - fMRI: 
All functional brain imaging was performed with a 3-axis gradient head-coil in a 3 
Tesla Siemens Trio system equipped for echo planar imaging. Phase and magnitude field 
maps were acquired to correct for image distortion (scan time: 1.5 min). 
 The SIRP requires 180 time points for a scan length of 6:00 minutes. The three first 
scans were discarded (3 DDAs) allowing the longitudinal magnetization to stabilize. The 
scanning parameters are listed in Table 3. 
 
Table 3: fMRI scanning parameters. Images were acquired using a gradient echo T2*-weighted 
sequence with an in-plane resolution of 3.1 mm. 
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5.4 Structural MRI data processing - Freesurfer 
All the subjects’ structural MRI data had been previously processed. Cortical 
reconstruction and volumetric segmentation based on high resolution structural MRI 
scans was performed with the Freesurfer surface reconstruction software (Fischl, et al., 
2002), which is documented and freely available for download online12. 
Freesurfer automatically identifies different structures of the brain and classifies all 
the brain tissue into gray matter, white matter or cerebrospinal fluid (CSF). It generates 
white matter and pial brain surfaces and assigns a neuroanatomical label to every voxel 
of the MRI volume (37 different labels in total). Further, it estimates the brain’s volume 
and cortical thickness. After processing and surface rendering, every subject’s brain has 
a cortical parcellation map and a subcortical segmentation map. Options to visualize the 
brain’s surface in 3 dimensions are also available either as pial/white matter surface, or 
inflated (gray/white matter interface), or even flattened depending on one’s needs. 
Parcellation maps can be overlaid on the brain’s surface. The subcortical segmentation 
can also be viewed overlaid on the structural image. Further, low-resolution functional 
data can be overlaid on the reconstructed brain, after applying the appropriate 
registration, for easy localization of brain activation. 
5.5 Definition of the dorsolateral prefrontal cortex region of interest 
As described in the introduction (see 4.3.1 ), the localization of the DLPFC in the 
human brain is considerably variable. Most often, the DLPFC is described as covering 
BA 46 and the lateral part of BA 9. From this description we created a ROI label for the 
DLPFC derived from the Freesurfer cortical parcellation map (Fischl, et al., 2002) and the 
use of conservative Talairach coordinates based on cytoarchitectonic studies (Fig. 6) 
(Rajkowska & Goldman-Rakic, 1995b) (Area 9: anterior/posterior (AP) +53 to +26, 
dorso/ventral (DV) +50 to +25; Area 46: AP +50 to +29, DV +36 to +14). The superior 
frontal gyrus, the rostral middle frontal gyrus and the caudal middle frontal gyrus 
Freesurfer parcellations were merged to form a dorsal prefrontal label. A coronal cut was 
applied on the latter ROI at Talairach coordinate y = 26 to conform it to the conservative 
Talairach criteria described in Rajkowska & Goldman-Rakic (1995b). A subsequent cut 
was made to separate the medial part from the lateral one on the superior edge of the 
medial wall of the brain (Fig. 7). This way, the ROI was individually defined for every 
subject to optimize subject specificity. The anatomically defined DLPFC ROI was then 
registered to the functional scans of every individual subject for further use in the fMRI 
analysis. 
Because of the previously mentioned inter-subject variability in the localization of 
the DLPFC, the definition of the boundaries of the DLPFC varies between studies. Potkin 
et al. (2009) use the WFU Pickatlas in MNI space (Maldjian, Laurienti, & Burdette, 2004; 
Maldjian, Laurienti, Kraft, & Burdette, 2003), while Wisco et al. (2007) limit their DLPFC 
                                            
12 http://surfer.nmr.mgh.harvard.edu/ ("Freesurfer surface reconstruction software,") 
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to a part of the Freesurfer rostral middle-frontal label. Our definition of the DLPFC is still 
to be improved based on future findings. 
 
 
Fig. 6: Left hemisphere of the Talairach and Tournoux grid system displaying the conservative 
Talairach coordinates of BA 9 and BA 46 as defined by Rajkowska and Goldman-Rakic (1995b). 
(Image taken from (Rajkowska & Goldman-Rakic, 1995b)) 
 
Fig. 7: The fours steps required for the creation of the DLPFC ROI. 
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5.6 Statistical analysis of the fMRI data – FSL 
The Functional Magnetic Resonance Imaging of the Brain (fMRIB) Software 
Library13 (FSL) was developed by the fMRIB analysis group in Oxford, UK. This software 
package is comprised of tools for the analysis of MRI, fMRI as well as DTI data from 
simple preprocessing steps such as non-brain voxel removal (the brain extraction tool - 
BET) to the elaborate fMRI Expert Analysis Tool (FEAT). FEAT is a very complete tool, in 
which one can set different parameters, like motion correction, intensity normalization, 
and registration to either a standard brain or a high-resolution image of a particular 
subject’s brain. Statistical analysis in FEAT is based on univariate general linear 
modeling (GLM), also known as multiple regression modeling. Univariate, as opposed to 
multivariate, means that the model is applied to a single voxel at a time and not to the 
whole volume. 
One can perform first level analysis of single runs of fMRI data, as well as average 
across several runs from one subject (cross-run analysis). Completion of a second-level 
FEAT analysis groups and averages cross-run analysis from several subjects. Finally, in 
the third-level analysis, one can compare different groups’ results, e.g. patients versus 
controls. Analysis was carried out using FEAT Version 5.92.  
5.6.1 First-level analysis 
pre-statistics 
The following processing was applied: 
 
1. Motion correction corrects for the movement of the subject’s head in 
the scanner. It uses the FMRIB's Linear Image Registration Tool 
(MCFLIRT) (Jenkinson, Bannister, Brady, & Smith, 2002). Motion 
correction estimates the motion from one time frame to the next 
(relative motion), but also from each time point to a reference 
image, the middle time frame (absolute motion). It uses rigid-body 
transformation. That means 6 degrees of freedom: 3 translations and 
3 rotations (roll, pitch and yaw) along the three axes x, y and z. 
2. Non-brain removal using the brain extraction tool (BET) (S. M. 
Smith, 2002). This removes all skull and non-brain tissue and allows 
for unwanted voxels to not be taken into account in the fMRI 
analysis. 
3. Spatial smoothing using a Gaussian kernel of full width at half 
maximum (FWHM) of 5 mm. The aim of spatial smoothing is to 
increase the dependency between one voxel and its neighbors, and 
to reduce noise without canceling out significant activation. It 
                                            
13 http://www.fmrib.ox.ac.uk/fsl ("FSL - FMRIB Software Library,") 
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assumes that the signal is more spatially correlated than the noise, 
which improves the signal-to-noise ratio. 
fMRI data is namely already spatially correlated before smoothing 
because two voxels lying next to each other have a high probability 
of representing two points in the brain having the same function. 
Additionally, the vascular system introduces blurring in the 
measured signal further increasing the inherent spatial correlation of 
fMRI data. 
Spatial smoothing also permits the use of the Random Field Theory 
(RFT) instead of the Bonferroni correction in order to correct for 
multiple comparisons induced by the GLM. The problem of multiple 
comparisons is that the probability of finding false positives (Type I 
error) is linearly correlated with the number of statistical tests. 
Bonferroni correction is too conservative for spatially correlated data 
and increases Type II errors (false negatives, i.e. missing true 
activation). The RFT reduces the value of the number of independent 
statistical tests based on the smoothness of the data14. 
4. Highpass temporal filtering to remove low frequency artifacts. 
Statistical analysis: 
Time-series statistical analysis was carried out using FMRIB's Improved Linear 
Model (FILM). In the GLM, a model that represents the signal expected to be found in 
the data is created based on the experimental design. For the SIRP block design, there 
are 7 explanatory variables (EV’s) (see the design matrix in Fig. 8): one for the time when 
the word ‘learn’ is displayed on the screen (lrn), one for the encoding period of all three 
loads (e1, e3, and e5), and one for the probing session of each load (p1, p3 and p5). The 
timing of these EV’s is extracted from the stimulus schedule of the SIRP. The waveform 
of the EV’s is then convolved with a hemodynamic response function (a gamma function 
with a half-width of 3 standard deviations and a mean lag of 6 seconds) in order to best 
fit the timing of the activation in the brain that slightly lags the actual stimulus because 
of physiological reasons. 
 
                                            
14 (Huettel, Song, & McCarthy, 2004) 
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Fig. 8: Design matrix for lower-level analysis. See text for details. 
Parameter estimates (PE’s) of every EV are then generated for every voxel 
depending on how well that voxel’s time-course fits the model. PE’s are then converted 
into statistical maps. In the model, one can also compare PE’s by setting up contrasts of 
PE’s (COPE) as well as F-tests to test for the association to the data of one EV related to 
another or to the baseline. A statistical image is created for every COPE. Our model has 
six COPES and one F-test: 
 
1. p1-v-fix: load 1 versus baseline. The Z statistic output image will 
display the activation produced by the probing sequences of load 1. 
 
2. p3-v-fix: load 3 versus baseline. The Z statistic output image will 
display the activation produced by the probing sequences of load 3. 
 
3. p5-v-fix: load 5 versus baseline. The Z statistic output image will 
display the activation produced by the probing sequences of load 5. 
 
4. p5-v-p1: load 5 versus load 1. This compares two stimulus types by 
subtracting one EV to another. Activation produced by both probe 1 
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and probe 5 is canceled by the subtraction. The resulting statistical 
map shows brain areas active for load 5 only, i.e. shows the load 
specific activation. 
 
5. p135-v-fix: sum of probe 1, probe 3 and probe 5. The statistical 
output is a sum of the activation resulting from each load during the 
probe epoch. Equal weight is given to all loads (e.g. is load 
independent). It is statistically useful to identify voxels that are more 
active during the overall task and within which to hunt for load 
specific activation. 
 
6. e135-v-fix: sum of encoding 1, encoding 3 and encoding 5. The 
statistical output is a sum of the activation resulting from each load 
during encoding. 
 
• F-test between probe 1, probe 3 and probe 5. The statistical output 
of the F test displays the regions of the brain in which there is 
activation for either loads. That is, it shows whether there is a 
general effect of probing task versus baseline. 
 
Registration: 
Registration of low resolution functional images to high resolution standard space 
images (MNI 15215) was carried out using FMRIB's Linear Image Registration Tool 
(FLIRT) with 12 degrees of freedom, allowing scaling and shearing of the image in 
addition to translation and rotation (Jenkinson, et al., 2002; Jenkinson & Smith, 2001). 
Registration to standard space is necessary in order to further analyze the data, averaging 
across the runs and performing group analysis. 
5.6.2 Cross-run analysis 
The cross-run analysis is based on fixed-effect (FE) modeling. It consists of a simple 
average across all three runs for each subject (see design matrix in Fig. 9), and increases 
the signal-to-noise ratio assuming that the signal is the same in all runs, while the noise 
is random. It tells us where the subject activates on average for each of the previously 
specified COPEs. FSL takes as input the three first-level analysis output files. 
 
                                            
15 Montreal Neurological Institute average of 152 brains of normal subjects. www.mni.mcgill.ca 
("Montreal Neurological Institute,") 
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Fig. 9: Design matrix for the cross-run analysis. 
 
Post-statistics: 
One can constrain the analysis to a specific area or ROI by applying a mask on the 
functional data before the completion of analysis. We performed pre-threshold masking 
with the DLPFC ROI labels in order to restrict the extraction of clusters. 
The original Z-statistic images were thresholded using z>2.3, and clusters were 
then tested for significance using RFT with a final significance test of p = 0.05 corrected 
for multiple comparisons (Forman, et al., 1995; Friston, Worsley, Frakowiak, Mazziotta, 
& Evans, 1994; Worsley, Evans, Marrett, & Neelin, 1992). The threshold for the 
minimum size of a cluster is based on the number of voxels in the whole dataset. FSL 
outputs a volume with every cluster being assigned a different color for easy 
visualization. The clusters are also reported in a numerically indexed list containing the 
following data: 
 
• A cluster index from 1 to n, n being the biggest cluster found in the 
volume 
• The number of voxels in each cluster 
• The p-value of the cluster 
• The z-value of the maximally active voxel of the cluster, as well as up to 
six other local maxima included in the same cluster 
• The coordinates of the maximally active voxel, and local maxima found 
within each cluster 
• The center of gravity (COG) of the cluster computed based on a weighting 
of the z-value of all voxels comprised in a cluster 
• The coordinates of the voxel with the maximum percent signal change 
from baseline for the COPE of interest 
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• The percent signal change of that voxel 
• The mean percent signal change across all voxels included in the cluster 
5.6.3 Group analysis and group comparison 
We performed a whole brain group analysis for both patients and controls using 
mixed effects analysis that allows extrapolating the results to the general population that 
the subjects were drawn from. We also performed group comparisons in order to 
determine whether patients have a different activation pattern relative to controls (two-
sample unpaired t-test) (see design matrix in Fig. 10). The group means and the group 
comparisons were only performed on contrast 5, that sums the activation induced by all 
three loads of the paradigm. 
 
 
Fig. 10: Design matrix for the group comparisons and the group means. Group A: controls. Group 
B: patients. (59 subjects: 35 patients and 24 controls) 
5.7 Automation of the analysis - FIPS 
The Functional Biomedical Informatics Research Network (fBIRN) Image 
Processing Stream (FIPS)16 was also used for data analysis. Originally created for data 
acquired by the Biomedical Informatics Research Network (BIRN17) under the direction 
                                            
16 https://xwiki.nbirn.net/xwiki/bin/view/Project-FIPS-Public/Home ("FIPS Wiki,") 
17 a consortium developing methods for multi-site functional imaging studies. http://www.nbirn.net/ 
("Biomedical Informatics Research Network (BIRN),") 
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of the National Institute of Health (NIH), necessary changes to its processing stream 
were made to be compatible with the MCIC data. FIPS is a software package that allows 
for the automated management of large multi-site fMRI studies. It provides a very 
specific data hierarchy for making its usage accessible to anyone with large 
neuroimaging datasets while simplifying the sharing of information. FIPS uses both FSL 
and Freesurfer as computational engines. The majority of the FSL functional image 
analysis was automated with FIPS. FIPS can also be used for easy visualization of the 
statistical analysis through Freesurfer. The output of the functional data is namely 
registered to the anatomical data preprocessed with Freesurfer. 
5.8 Quality assurance - QA 
The quality assurance (QA) of the data is a key step for the successful outcome of 
the analysis. There are different reasons that can cause a subject’s data to be classified as 
being of too poor quality to be processed without compromising the power of the 
analysis. The QA processing for this data was the following: 
Disenrolled subjects: 
According to the rules of the Institutional Review Board (IRB), any subject had the 
right to disenroll from the study at any time without further explanation. That data is not 
to be used for any analysis. 
Behavioral criteria: 
Missing data was defined as a block completed with less than a 70% accuracy rate 
(10 out of 14 correctly identified), and/or with more than 6 probes not answered within 
a block. Subjects that missed four or more of the 18 SIRP blocks comprising the task 
(three runs, with six blocks per run) were considered as behavioral dropouts. They were 
not further processed into the analysis. 
Missing behavioral data not due to subject error: 
Technical issues can cause behavioral data (reaction time and accuracy) to not be 
recorded as subjects are performing the task. The functional data is nevertheless 
acquired normally. Those cases were retained for the functional analysis. 
Freesurfer processing of the structural data: 
The quality assurance of the Freesurfer processing of the structural data was semi-
automated with a tool embedded in the Freesurfer software package. The tool checked 
whether any step of the processing was missed, and captured snapshots of the following: 
 
• The subcortical segmentation: 7 coronal slices and one sagittal slice per 
hemisphere of the skull-stripped brain. 
• The white and pial surfaces: 7 coronal slices and one sagittal slice per 
hemisphere of the skull-stripped brain. 
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• The inflated brain: a lateral, a medial, and an inferior view of both the 
right and the left inflated hemispheres. 
• The curvature map: a lateral, a medial and an inferior view of the 
curvature map (gyri in green, and sulci in red) overlaid on both 
hemispheres of the inflated brain. 
• The cortical parcellation: a lateral, a medial and an inferior view of the 
cortical parcellation overlaid on both hemispheres. 
 
We later examined those snapshots for every subject searching for abnormalities in 
the skull stripping and/or in the white and pial surface delineation. If an abnormality was 
found, we performed minimal edits according to the Freesurfer standard manual before 
rerunning the Freesurfer processing on the problematic subjects. 
Registration to high-resolution anatomical image: 
We used a Freesurfer tool for a boundary-based registration of the functional data 
to the high-resolution structural data. We manually checked a subset of the subject’s 
registrations. 
Brainmask: 
The brainmask is a binary volume created by FSL based on the first functional MRI 
volume after brain extraction. It is meant to cover all voxels belonging to the brain only, 
but the algorithm does not always successfully classify every single voxel as brain or 
non-brain. Also, bad positioning in the scanner can cause the functional scans to not 
cover the whole brain. The resulting brain-mask can therefore be of somewhat 
insufficient quality. This may cause problems at the level of group analysis as the masks 
from all subjects are concatenated to create a group mask. The group mask only 
includes voxels where every single subject presents a voxel in its individual mask. Masks 
were checked manually at the cross-run level, and, if corrupted, further checked at the 
first level for missing slices due to bad positioning of the subject in the scanner. Subjects 
with badly corrupted masks were discarded from the analysis. 
Motion and mean intensity of functional data: 
We used the fMRI Artifact Detection Tools (ART) developed by Whitfield-Gabrieli 
(2009) to perform automated detection of outliers, both for motion and global mean 
image intensity. The program was set to flag time frames that had more than 1 mm of 
motion in either the x, y or z direction (movement threshold). It also controlled for 
rotational (angular) motion, flagging time frames having more than 0.1 radians of motion 
around the three axes (roll, pitch and yaw) (rotation threshold). Further, ART controlled 
for time frames, which mean brain activation intensity differed by more than three 
standard deviations from the mean over all time frames of one run (z-threshold) also 
called ‘spikes’. Spikes are artifacts caused by the scanner. The user can modify all three 
thresholds of this program to best fit the data of interest. 
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ART can only be used on data that has already been analyzed at a first-level with 
FSL. Following the first-level motion correction step with MCFLIRT, FSL outputs a 
motion parameter file that is used as an input to the ART tool. ART uses that file, as well 
as the functional imaging data to detect and flag outliers. Subsequently, the first-level 
FSL analysis has to be performed once again, this time excluding the outlying time 
frames of the GLM. This was performed automatically by adding an EV in the GLM for 
every time frame to be excluded. 
Clusters in the DLPFC: 
After having averaged all three runs for every subject and performed pre-threshold 
masking with the DLPFC, we visually inspected all subjects in 3 dimensional volumes. 
The goal was to assess whether an activation cluster was part of the DLPFC or not, since 
our definition of the DLPFC ROI is still to be improved and potentially covering too large 
of a territory. Also, if a subject had several clusters that could be considered as DLPFC in 
one hemisphere, then only the cluster with the maximally active voxel would be taken 
into account. We namely had to reduce the number of clusters in each hemisphere to 
one in order to ease this first approach in exploring the heterogeneity of the activation. 
An expert neuroanatomist gave final approval of the cluster selection for every subject. 
5.9 Investigation of the spatial heterogeneity of the activation in the 
DLPFC 
The following process was based on contrast 5 only, summing the activation 
triggered by all WM loads. Based on the COG of the clusters in the DLPFC of every 
individual subject, calculated by FSL, we calculated a mean COG for each hemisphere 
and each group, i.e. patients and controls, on which we performed a statistical test of 
significance to determine whether patients’ mean differed from the control’s. We then 
calculated the Euclidian distance (ED), which is a simple metric distance, of each 
subject’s cluster’s COG to the mean COG. Further, we tested whether that distance was 
significantly different in patients and controls. 
The Euclidian distance between two points in 3 dimensions is defined as follows: 
 
Group mean COG: mCOG = (mx, my, mz) 
Individual subject’s COG: iCOG = (ix, iy, iz) 
 
! 
ED = (mx " ix )
2
+ (my " iy )
2
+ (mz " iz )
2  
 
We calculated each population’s covariance for both hemispheres and tested 
whether there was a significant difference between patients and controls. The 
covariance has the advantage of considering the 3 dimensional spatial locations of the 
data, which is lost in the simple measure of the ED, allowing a more meaningful analysis 
of the spatial heterogeneity. 
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6 Results 
6.1 Results of the quality assurance 
Disenrolled subjects: 
One control got disenrolled from the study. 
Behavioral criteria: 
Two subjects missed four or more of the 18 SIRP blocks comprising the task. These 
behavioral dropouts were one patient and one control.  
Missing behavioral data: 
Two patients and one control had missing behavioral data for a complete run not 
due to subject error. They were kept for the fMRI analysis. 
Freesurfer processing of the structural data: 
One control and one patient were identified as having a pial surface encompassing 
non-brain voxels on the edge of the occipital cortex. After some minor manual edits of 
the structural MRI volume, the Freesurfer processing yielded a corrected pial surface. 
Registration to high-resolution anatomical image: 
We manually checked the registration of the functional data to the anatomical data 
of a subset of patients and controls. The approval of the registration for those subjects 
was further extrapolated onto the whole cohort. 
Brainmask: 
One patient had to be discarded from the analysis due to a faulty acquisition with 
incomplete brain coverage, hence a corrupted mask not covering the whole brain. 
Motion and mean intensity: 
There are 177 time frames in total in every run. One patient had over 40 outlying 
frames in every run (47 for run 1, 45 for run 2, and 42 for run 3) and was consequently 
discarded from further analysis. One control and one patient had over 50 outlying time 
frames in a single run (54 and 56 respectively, both in run 1). When averaging across 
runs, two runs showed to not give reliable results concerning the analysis of clusters of 
activation in the DLPFC. We therefore decided to drop those subjects from the analysis. 
Two subjects had 24 (13.5%) outliers in run 1. All other runs had less than 16 (9%) 
outliers. All subjects with runs having less than 26 outlying time frames were retained for 
further analysis. 
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After complete QA, the average number of outlying time frames over all three runs 
(a total of 177x3=531 time frames) was 9 for controls and 7.5 for patients, for an average 
of 3 (1.7%) time frames per run for controls and 2.5 (1.4%) for patients. 
Clusters in the DLPFC: 
Eight subjects turned out to not have any clusters of activation in the DLPFC. Of 
those, five were controls and three were patients. Additionally, two controls had one 
cluster each in the right hemisphere, but those clusters were considered to be located 
too frontally. Consequently, ten subjects were not included in the calculation of the 
heterogeneity of the activation in the DLPFC due to lack of activation in the DLPFC. 
Six subjects had more than one cluster to take into account. One control and two 
patients had two clusters in the left hemisphere. Two patients had two clusters in their 
right hemisphere. One control had two clusters in both hemispheres. In those cases, the 
cluster with the highest z-value at its maximally active voxel was kept for further 
analysis. 
Out of the 47 subjects (15 controls and 32 patients), 42 (14 (93%) controls, 28 
(87.5%) patients) had a cluster in the left hemisphere, and 35 (12 (80%) controls, 23 
(72%) patients) had a cluster in the right hemisphere. 30 subjects had a cluster in both 
hemispheres (11 (73%) controls, and 19 (59%) patients). A subject not having a cluster 
in one of the hemisphere necessarily had one in the other. It would otherwise not have 
been kept for the analysis. 
6.2 Group mean and group comparison 
We averaged all cross-run analysis of the controls and the patients separately in 
order explore the general trends of activation in patients versus controls. The group 
analysis statistical maps for COPE 5 (summing activation caused by all three load levels) 
are presented on both hemispheres of one subject’s inflated brain in Fig. 11 for controls 
and in Fig. 12 for patients. The outlines of four ROIs suggested to subserve WM are 
overlaid on the brain surface for easy localization of activation blobs. Those are: the 
DLPFC, the primary motor cortex of the hand, the intraparietal sulcus and the insula. 
In addition to averaging across all subjects of one group, we performed a group 
comparison to test whether patients activate certain areas significantly more than 
controls in response to the paradigm. The group comparison statistical map is pictured 
in Fig. 13 overlaid on one subject’s inflated brain. 
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Fig. 11: Statistical map of group analysis of healthy controls overlaid on one subject’s inflated brain. 
The map is truncated to display only positive activation. Colored outlines define ROIs: white: DLPFC; 
blue: primary motor cortex of the hand; green: intraparietal sulcus; yellow: insula. Color scale bar defines 
z level of activation. Right hemisphere is on the left. 
 
 
Fig. 12: Statistical map of group analysis of schizophrenia patients overlaid on one subject’s inflated 
brain. The map is truncated to display only positive activation. Colored outlines define ROIs: white: 
DLPFC; blue: primary motor cortex of the hand; green: intraparietal sulcus; yellow: insula. Color scale bar 
defines z level of activation. Right hemisphere is on the left. 
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Fig. 13: Group comparison between schizophrenia patients and healthy controls overlaid on one 
subject’s inflated brain. Warm colors show where patients activate more than controls and cold colors 
show where controls activate more than patients. Colored outlines define ROIs: white: DLPFC; blue: 
primary motor cortex of the hand; green: intraparietal sulcus; yellow: insula. Color scale bar defines z 
level of activation. Right hemisphere is on the left. 
6.3 Study of the fMRI activation indices in the DLPFC 
We started by calculating the mean of the volumes of the clusters we selected in 
the DLPFC. The mean volume is reported in number of voxels. We tested whether the 
mean cluster volume was significantly different between patients and controls in both 
hemispheres. There was no significant difference between patients and controls in either 
hemisphere with p=.33>.05 and p=.47>.05 in the left and right hemispheres respectively  
(see Table 4). 
Table 4: Mean cluster volume in number of voxels for each group and both hemispheres, and t-tests 
of significance between the two groups. 
 Hemisphere 
Normal 
subject 
Schizophrenic 
subject 
t p 
left 309.27 310.97 0.99 .33 Mean cluster 
volume (# of 
voxels) right 344.92 305.71 0.75 .47 
 
We computed a mean COG by averaging the spatial coordinates of each 
individual’s cluster’s COG, extracted from the FSL analysis, giving us one mean spatial 
coordinate vector per group and per hemisphere. The coordinates are displayed in 
(Table 5). To test for a significant difference between the means of the two groups we 
used Hotelling’s T-square statistical test that is a generalization of Student’s t-test for 
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multivariate data. The null hypothesis claims that the mean COG vectors of patients and 
controls are equal in a hemisphere. With a p=.66>.05 and p=.69>.05 in left and right 
hemispheres respectively, the null hypothesis cannot be rejected. Consequently, the 
mean COGs do not significantly differ between patients and controls. 
 
Table 5: Coordinates in mm of average COG for each group and both hemisphere, and Hotelling’s 
T-square test of significance between the means of the two groups. 
 Hemisphere Group x y z F p 
control -36.71 42.35 19.42 
left 
schizophrenic -37.36 43.60 17.06 
0.53 .66 
control 35.53 43.04 19.30 
Coordinates of 
average COG 
(mm) in 
standard space right 
schizophrenic 36.47 43.87 16.59 
0.49 .69 
 
The spatial coordinates of the average COG for each groups as well as the COG for 
every subject are plotted in a 3 dimensional reference frame in Fig. 14 for the left 
hemisphere and in Fig. 15 for the right hemisphere. 
 
Fig. 14: Average COG and individual COG for patients and controls in the left hemisphere. 
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Fig. 15: Average COG and individual COG of patients and controls in the right hemisphere. 
 
Next, we calculated the Euclidian distance (ED) from the average COG of both 
groups to each subject’s COG. The mean of the Euclidian distances computed for both 
groups in each hemisphere are reported in Table 6. The EDs were tested for significance 
between the two groups. The distances did not show a statistically significant difference 
between patients and controls, as the null hypothesis of the distances being equal for 
patients and controls could not be rejected (p=.78>.05 in the left hemisphere, and 
p=.38>.05 in the right hemisphere). 
 
Table 6: Mean and standard deviations of the Euclidian distances (mm) to the average COG of each 
group, and tests of significance between the two groups. 
 Hemisphere Normal subjects 
Schizophrenic 
subjects 
t p 
Left (n=42) 7.18 ± 3.63 8.55 ± 3.73 0.28 .78 Mean ED distance 
to group COG 
(mm) Right (n=35) 8.21 ± 3.92 8.41 ± 4.17 0.89 .38 
 
The measure of the ED is a scalar and hence does not take into account the 3 
dimensional spatial location of each COG. To consider this information, we computed 
 38 
the covariance matrices of the COGs of both groups. The covariance is a measure of the 
extent to which the x, y, and z coordinates of the COGs vary together for each group. 
We tested the null hypothesis of the covariance matrices defining the COGs of patients 
and controls being equal using the χ2 large-sample approximation of Box’s M test (Box, 
1949, 1950). The results are listed in Table 7. The null hypothesis could not be rejected 
in the right hemisphere (p-value 0.89>0.05). However, in the left hemisphere, a p-value 
of 0.03<0.05 rejects the null hypothesis suggesting the covariance of patients to be 
significantly different from controls. This means that the x, y and z coordinates of the 
control’s COGs do not vary in the same way as the patient’s ones do. 
Table 7: p-value of the χ2 large-sample approximation of Box’s M test, testing the H0: 
Cov(COGcontrols)=Cov(COGpatients) in the left and right hemispheres. 
 Hemisphere p 
left 0.03 Testing equality of 
covariance matrices right 0.89 
 
This result can be 3 dimensionally represented. The covariance matrices namely 
have the property of defining an ellipsoid, the eigenvectors representing the principal 
directions, and the inverse of the square root of the eigenvalues defining the half 
intensity, or equatorial radii, of its three axes. Those ellipsoids are pictured in Fig. 16 
(See  
Appendix A for details on the covariance matrices). The ellipsoids of both groups 
are plotted in the same reference frame for each hemisphere for easy visual comparison. 
The significant difference in the covariance of the COGs of patients and controls in the 
left hemisphere is suggested by that graph, as the two ellipsoids have a smaller common 
space coverage in the left than in the right hemisphere. 
 
 
Fig. 16: Ellipsoids as defined by the covariance matrices of the COGs for patients (red) and controls 
(blue). Left: left hemisphere. Right: right hemisphere. 
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7 Discussion 
Overall, schizophrenia patients and healthy controls showed activity in areas 
involved in the network underlying WM when performing the task in both the right and 
the left hemispheres, the latter showing a slightly more robust activation. The modified 
SIRP indeed requires some verbal processing known to be lateralized to the left 
hemisphere. Statistical activation maps of group averages displayed activation in the 
intraparietal sulcus, the insula, the primary motor regions as well as the DLPFC as seen 
in Fig. 11 for controls and Fig. 12 for patients. Nevertheless, patients activated all those 
particular regions slightly more than controls as can be seen in the group comparison 
map in Fig. 13, in which the red colored blobs describe where patients show more 
activation than controls. In fact, several controls turned out to not show any significant 
activation in the DLPFC, which probably contributes to the lower activation of that area 
in the group average of controls. This is in line with the inefficiency theory presented in 
Callicott et al.’s study (2003), which suggests that patients have to make more efforts in 
order to reach the same performance level as controls. 
Our analysis was limited to the contrast showing activation of any of the three WM 
memory loads used in the SIRP. In order to assess for the effect of the task’s load and 
match the patients and the controls for performance and not only for WM load (e.g. 
compare controls and load 5 with patients at load 1), other contrasts should be used for 
further analysis, such as the one comparing load 5 to load 1. 
Controls showed very little activation of the DLPFC, and it was mostly localized on 
the posterior/inferior edge of our DLPFC ROI. Whereas patients in general recruited a 
more extended area of the DLPFC as we have defined it. It is to note though, that the 
group means and the group comparison maps are overlaid on one subject’s inflated 
brain. That requires registration of the image from a standard stereotaxic space to the 
subject’s native space. The ROIs as presented in Fig. 11 to Fig. 13 are therefore not 
representative of the whole cohort. Nevertheless, the fact that most of the activation 
induced by the SIRP lies on the edge of our ROI and overflows onto the VLPFC, situated 
inferior to the DLPFC, suggests that our search territory might benefit from an extension 
onto the VLPFC by including additional Freesurfer parcellations in the ROI, such as the 
pars triangularis and the pars opercularis together defining Broca’s area in the left 
hemisphere. Wolf et al. (2006) have indeed found that a particular SIRP recruits the 
VLPFC in addition to the DLPFC. 
A possible explanation for the low level of activity on the DLPFC of controls is that 
the task is too easy, and becomes quickly automated. The accuracy rate for this 
paradigm is high both for controls and patients. Following this, the SIRP used in this 
study might have to be improved and rendered more difficult in order to distinguish a 
more significant difference between the activation patterns of patients and the controls. 
Adding a follow up visit to the protocol may show significantly different patterns of 
activation between controls and patients, the latter having shown incapacity to automate 
the task despite steady training leading to unreliable activation patterns during two 
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performances of the same task separated by some amount of time. It is very likely that 
schizophrenia patients show less capacity in developing a strategy for handling the task 
causing worse performance than controls and differential recruitment of the DLPFC 
(Manoach, et al., 2000). 
Our quality assurance process yielded artifact-free data for the group fMRI analysis, 
but also showed us that the data was of good quality from the beginning since we only 
had to drop 4 (6.25%) subjects out of the 64 because of one of our quality criteria, not 
considering the subject that got disenrolled from the study. 
 
For the analysis of the COG of the clusters in the DLPFC, more subjects (mostly 
controls) were dropped (12 (18.75%) in addition to the 5 previously dropped). But that 
was solely due to the algorithm that could not take into account subjects with no data, 
i.e. the subjects with no clusters of activation in the DLPFC, and not due to unsatisfying 
data quality. Thus, controls showed less activation than patients in the DLPFC, but by 
comparing only the subjects of both groups that did have clusters in the DLPFC, the 
volume (in number of voxels) of those clusters did not differ. 
The Euclidian distance between each subject’s cluster’s COG to the group’s mean 
COG in both the right and the left hemisphere was not significantly different between 
schizophrenia patients and healthy controls. The mean COG of the clusters of activity 
did not differ between both groups. The covariance of the COGs of patients and controls 
was significantly different in the left hemisphere, but not in the right. The statistical test 
does not tell us what group has a bigger variance than the other. Nevertheless, the 
determinant of the covariance matrix is correlated to the extent of the covariance. In this 
case, the covariance matrix of the patients had a determinant of one order of magnitude 
bigger than the controls in the left hemisphere (see Appendix A). In the left hemisphere, 
the mean of the COGs does not significantly differ, while the covariance does, which 
indicates a greater scatter of the COGs in patients relative to controls. This suggests that 
schizophrenia patients show significantly greater spatial heterogeneity of the indices of 
activation evoked by the WM paradigm in the DLPFC of the left hemisphere as proposed 
by Manoach et al. (2000). A greater spatial heterogeneity of DLPFC activation in 
schizophrenia patients could potentially be correlated to white matter abnormalities. 
The same conclusion cannot be drawn for the right hemisphere. 
 
The methods we used for the analysis of the spatial localization of fMRI activation 
indices in the DLPFC were a first approach to that particular aspect of this study. We will 
now discuss their limitations. 
fMRI data is inherently noisy. The amplitude of the BOLD signal that is of interest 
for the analysis of the functionality of the brain is not much larger than the noise and 
hence difficult to extract from it. 
FSL is a MRI analysis tool in constant development and the way in which it 
computes the COG of an activation cluster might not be the most representative of the 
data. Moreover, the clusters for which the COG was calculated were limited to the 
white/gray matter border, because we filtered the data with ROIs that are surface based 
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(i.e. surface-based labels following the white/gray matter intersection), which somewhat 
biases the data on which the COG is computed. Even though the surface of the brain is 
where we expect the actual BOLD activation, and knowing the fact that the smoothing 
performed during the preprocessing of the data contributes to spreading the signal 
beyond the surface into the white matter. The computation of the COG might be more 
realistic with the use of an ROI, which thickness is dilated of a couple of voxels in order 
to cover a more consistent area of the activation. By filtering the data with such a limited 
area and performing cluster based correction for false positives our analysis may have 
become too conservative and rejected true positives. 
Further, we had to visually inspect all subjects in order to select the clusters of 
interest in the DLPFC, because some subjects had activation in the very frontal and 
superior parts of the ROI that should not be included in the DLPFC according to our 
study of the literature on DLPFC delimitation. Following this, to ease the analysis, the 
ROI could be reduced in size by applying a frontal cut at the Talairach coordinate y=53 
based of the cytoarchitectonic study performed by Rajkowska & Goldman-Rakic 
(1995b). On the other hand, by excluding clusters located too frontally and too 
superiorly, we may have been too conservative in assuming the spatial location of the 
DLPFC, and discarded brain areas actually subserving WM. Most cytoarchitectonic 
studies defining the DLPFC are based on normal controls and not patients with brain 
disorders. Neuropsychiatric disorders such as schizophrenia may lead to modification in 
the cytoarchitechtonics and/or anatomy. In such a case, the DLPFC needs to be 
specifically defined for patients, which was not the case in this study. Park et al. (2004) 
have pointed out how the definition of several ROIs differ in schizophrenia patients with 
the use of probability maps. 
In particular, the location of the DLPFC is quite variable across subjects (Rajkowska 
& Goldman-Rakic, 1995b). Potentially, this variability is even greater among 
schizophrenic subjects (Manoach, 2003). Brain imaging analysis attempts to correct for 
that variation across subjects by performing spatial normalization and smoothing of the 
data. However, most spatial normalization algorithms are based on the anatomy of 
healthy subjects. An asset of our definition of the DLPFC is that it is specific for each 
subject based on its Freesurfer cortical parcellation. 
In parallel to using the DLPFC for the analysis, we could use a control ROI 
covering an area known to be involved in the processing of WM tasks but that has not 
been suggested to show any particular spatial heterogeneity of activation in 
schizophrenia patients, such as the intraparietal sulcus. 
All calculations related to the COG were based on only one cluster per subject and 
per hemisphere. In some cases, several clusters were eligible to be included in the 
DLPFC but only one could be included for the algorithm to work. This might have 
biased the results by reducing heterogeneity of activation to only one location. Another 
bias is that many controls were dropped due to having no clusters in the DLPFC. We 
would like to find a method allowing for several clusters to be taken into account in one 
hemisphere and also find a way of taking into account the subjects that do not show any 
activation. 
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Other factors that can have an effect of the brain activation patterns in 
schizophrenia patients are for example, the genetic aspects of the disease (e.g. effect of 
COMT and MTHFR), the antipsychotic treatment, or the smoking history of the patients. 
In this study those features certainly contributed to the variability of the data but are not 
corrected for. 
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8 Conclusion 
On average, both schizophrenia patients and controls showed activation in the 
brain regions expected to be recruited for the use of WM. The activation tended to be 
more robust in the left hemisphere. The hypothesis suggesting that patients show more 
spatially scattered activation in the DLPFC than controls while performing a task 
requiring the use of WM was supported by our findings in the left hemisphere, but not in 
the right one. Indeed, patients did show significantly greater covariance, relative to 
healthy controls, of the localizations of the COGs of activation clusters in the DLPFC of 
the left hemisphere in response to a task requiring WM. Even though the spatial scatter 
of the COGs was more heterogeneous for patients, the Euclidian distance to the group’s 
mean COG did not significantly differ between controls and patients. 
We performed a careful quality assurance before processing the data. Nevertheless, 
it is of note that the methods developed for this particular study have limitations that 
would be worth correcting for in order to replicate our results and confirm the 
hypothesis. Those limitations are considered in the discussion, and lead to future ideas 
for the investigation of the matter. 
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10 Appendix A 
Left hemisphere 
 
Controls: 
 
Covariance matrix SL1 = 
11.0598    2.3369      13.1365 
2.3369      22.5442    -14.3742 
13.1365    -14.3742   36.0018 
 
Determinant of SL1: 
det(SL1) = 1.7218e+03 
 
Eigenvectors (each column represents an eigenvector): 
VL1 = 
   -0.7768    0.5674    0.2731 
    0.4155    0.7878   -0.4546 
    0.4731    0.2397    0.8478 
 
Eigenvalues: 
λ1 = 1.8089 
λ2 = 19.8539 
λ3 = 47.9430 
 
____________________________ 
 
Patients: 
 
Covariance matrix SL2 = 
19.3846   11.4895   -5.9811 
11.4895   26.8048  -20.6537 
-5.9811  -20.6537   44.0426 
 
Determinant of SL2: 
det(SL2) = 1.0681e+04 
 
Eigenvectors (each column represents an eigenvector): 
VL2 = 
    0.5918    0.7603   -0.2680 
   -0.7366    0.3749   -0.5629 
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   -0.3275    0.5305    0.7819 
 
Eigenvalues: 
λ1 = 8.3927 
λ2 = 20.8766 
λ3 = 60.9627 
Right hemisphere 
 
Controls: 
 
Covariance matrix SR1 = 
   27.4930  -15.5484   -2.6141 
  -15.5484   27.6845  -13.5284 
   -2.6141  -13.5284   35.0878 
 
Determinant of SR1: 
det(SR1) = 1.1903e+04 
 
Eigenvectors (each column represents an eigenvector): 
VR1 = 
    0.5885   -0.6874    0.4256 
    0.7050    0.1786   -0.6864 
    0.3958    0.7040    0.5897 
 
Eigenvalues: 
λ1 = 7.1087 
λ2 = 34.2088 
λ3 = 48.9477 
 
____________________________ 
 
Patients: 
 
Covariance matrix SR2 = 
24.6200   -3.5124     -10.5928 
-3.5124    25.9029    -21.8930 
-10.5928  -21.8930   41.5878 
 
Determinant of SR2: 
det(SR2) = 9.6726e+03 
 
Eigenvectors (each column represents an eigenvector): 
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VR2 = 
    0.4495    0.8700   -0.2026 
    0.6952   -0.4831   -0.5323 
    0.5609   -0.0984    0.8220 
 
Eigenvalues: 
λ1 = 5.9671 
λ2 = 27.7685 
λ3 = 58.3751 
 
